VanEck Biotech Financial Statements From 2010 to 2024
| BBH Etf | USD 151.99 1.02 0.67% |
Check VanEck Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VanEck main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . VanEck financial statements analysis is a perfect complement when working with VanEck Biotech Valuation or Volatility modules.
VanEck |
VanEck Biotech ETF ETF Beta Analysis
VanEck Biotech's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current VanEck Biotech Beta | 0.85 |
Most of VanEck Biotech's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VanEck Biotech ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, VanEck Biotech ETF has a Beta of 0.85. This is much higher than that of the VanEck family and significantly higher than that of the Health category. The beta for all United States etfs is notably lower than that of the firm.
VanEck Biotech ETF Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Biotech's current stock value. Our valuation model uses many indicators to compare VanEck Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Biotech competition to find correlations between indicators driving VanEck Biotech's intrinsic value. More Info.VanEck Biotech ETF is second largest ETF in price to earning as compared to similar ETFs. It is third largest ETF in price to book as compared to similar ETFs fabricating about 0.16 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Biotech ETF is roughly 6.45 . Comparative valuation analysis is a catch-all model that can be used if you cannot value VanEck Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VanEck Biotech's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VanEck Biotech's earnings, one of the primary drivers of an investment's value.About VanEck Biotech Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include VanEck Biotech income statement, its balance sheet, and the statement of cash flows. VanEck Biotech investors use historical funamental indicators, such as VanEck Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although VanEck Biotech investors may use each financial statement separately, they are all related. The changes in VanEck Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VanEck Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on VanEck Biotech Financial Statements. Understanding these patterns can help to make the right decision on long term investment in VanEck Biotech. Please read more on our technical analysis and fundamental analysis pages.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VanEck Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VanEck Biotech's short interest history, or implied volatility extrapolated from VanEck Biotech options trading.
Pair Trading with VanEck Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VanEck Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with VanEck Etf
| 0.87 | IBB | iShares Biotechnology ETF | PairCorr |
Moving against VanEck Etf
| 0.55 | RSPY | Tuttle Capital Management | PairCorr |
| 0.43 | DSJA | DSJA | PairCorr |
The ability to find closely correlated positions to VanEck Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VanEck Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VanEck Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VanEck Biotech ETF to buy it.
The correlation of VanEck Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VanEck Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VanEck Biotech ETF moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VanEck Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of VanEck Biotech Correlation against competitors. Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.